ResMed, the #1 global producer of CPAP machines and masks to treat sleep apnea acquiresSomnoware, a U.S. leader in sleep and respiratory care diagnostics software. Financial details of the acquisition were not disclosed.
Somnoware software streamlines the processes of physicians and sleep labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering treatment equipment, setting up appointments, tracking therapy compliance, and electronically providing this information directly into a patient’s electronic health record.
As part of the acquisition, Somnoware will retain all staff and be integrated into ResMed’s Sleep & Respiratory Care business. Somnoware platform will remain an open platform to enable sleep labs, pulmonary function testing facilities, and physicians to view results from various testing solutions and help diagnosed patients get onto the treatment they need faster.
Two years after biosimilars became available in the U.S., a higher proportion of patients using brand-name biologics were paying out-of-pocket costs, which were also, on
Early detection of Alzheimer’s disease-related changes in Parkinson’s disease and dementia with Lewy bodies could be made possible by monitoring the amyloid-β (Aβ) and phosphorylated
M&A: ResMed Acquires Somnoware to Expand Sleep Management Offerings
by Fred Pennic Leave a Comment
What You Should Know:
Biosimilars haven’t always yielded lower out-of-pocket costs for patients, study finds
Two years after biosimilars became available in the U.S., a higher proportion of patients using brand-name biologics were paying out-of-pocket costs, which were also, on
Planet 13 PLNHF Stock analysis (How to make money with PLNHF Stock)
Neurofilament light chain identified as early marker for Parkinson’s and dementia with Lewy Bodies
Early detection of Alzheimer’s disease-related changes in Parkinson’s disease and dementia with Lewy bodies could be made possible by monitoring the amyloid-β (Aβ) and phosphorylated